Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
This guide compares risk levels between bonds and stocks in retirement, outlining factors like market cycles, duration, and income needs.
28,627 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
The space-launch landscape is shifting as Blue Origin faces a setback. This could paradoxically amplify SpaceX's IPO ...
Hynix’s move onto the Nasdaq marks a watershed moment for foreign listings in the U.S. tech space. This article break...
As Netflix stumbles, investors wonder if Disney down 2026 offers a rare contrarian opportunity. This article digs int...
Wheels Up Experience is in the spotlight as its stock faces a sharp decline. This article breaks down the primary cau...
Bitcoin often sparks heated debates about what it is really worth. This article argues the core mistake is treating p...
IonQ is leading the field among pure-play quantum stocks in 2026, delivering a positive year-to-date return while its...
AbbVie’s latest results reveal more than a quarterly beat. This article breaks down the growth engines behind the imp...
A fresh milestone has emerged as the crypto markets push toward the global crypto mcap $3.22. XRP leads gains while b...
Florida once drew nonstop investor attention. A survey from Redfin says that momentum is cooling, reshaping how buyer...
Investors are debating whether Microsoft stock is a steal right now. This deep-dive breaks down valuation, cash flow,...
A massive stockpile of used nuclear fuel sits in storage, but new tech could turn that waste into energy. This invest...